After the opening ceremony, the academic communication begins in stroke hotspot forum.
Prof Xiaosong GU, the academician of Chinese Academy of Engineering, showed us a series of achievements on the constructions and applications of nervous engineering in the recent 20 years. He integrally demonstrated the scientific research strategy from in vitro to in vivo, from experimental research to clinical translational application. Moreover, he reminded all the meeting delegates to attach more importance to personal intellectual property protection.
Prof Yongjun WANG introduced a portion of outcomes of their multi-center clinical trial in recent times. This trial focused on the therapeutic effects of anti-platelet drugs and drug-resistant genes. The data has been accepted by JAMA. It was the first time that one of international first-class journals accepts the precision medical research from China. We finally make a voice in the world.
Prof Raul G Nogueira, from Emory University in America, introduced the indicator for endovascular therapy. He proposed that the time period from stroke onset to the arrival at hospital may not be an absolute indicator. The mismatch in imaging and existence of collateral circulation were the two important determinants for prognosis.
Prof David S Liebeskind put forward the precision medicine based on hemodynamics in cerebrovascular diseases. He advocated that the development of cerebrovascular diseases can be a paradigm in precision medicine through multidisciplinary collaborations and massive data applications.